PubMed Health⌕ Search

Biomedical subjects

J L Pugh

Publications and source records attributed to J L Pugh.

6 recordsLinked to original sources

Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture.

Epidermal growth factor (EGF) and its fetal form, transforming growth factor alpha (TGF-alpha) are renal mitogens which induce epithelial hyperplasia, proximal tubular cyst formation (TC), and accelerated distal nephron differentiation in metanephric organ culture. To delineate the intracellular mechanisms mediating these growth factor effects, we studied the specific role of the epidermal growth factor receptor (EGF-R), the common receptor for both ligands, as an activated tyrosine kinase in TC formation and nephrogenesis. Fetal murine metanephric explants were incubated for 120 hours in control, and EGF (15 ng/ml)/TGF-alpha (10 ng/ml) supplemented medium with and without EGF-R blocking monoclonal antibody (50 mg/ml), or tyrosine kinase inhibitor. EGF-R tyrosine kinase inhibition was achieved by incubation with a synthetic tyrphostin (TP B42) (0.1 microM) or genestein (5.5 micrograms/ml). The following parameters were assessed: (a) segment-specific nephron development using morphometry and immunohistology; (b) tubular epithelial hyperplasia by protein content and BrdU uptake; and (c) TC formation by morphometric cystic index. Both growth factors produced hyperplastic proximal TC, significantly increased explant growth, and significantly increased distal nephron differentiation. Inhibiting the ligand-EGF-R interaction with EGF-R blocking monoclonal antibody abolished all growth factor-induced effects and resulted in increased amounts of undifferentiated mesenchyme and decreased distal nephron differentiation. Inhibition of EGF-R tyrosine kinase activity with either Tyrphostin B42 or genestein blocked TC formation and produced nodular blastemal hyperplasia and decreased distal nephron differentiation.

Animals↗

Bradykinin does not contribute to hypotension in early canine endotoxemia.

Previous work in this and other laboratories has demonstrated that captopril exacerbates the hypotension produced in dogs by endotoxin. This depressor effect of captopril could result from the potentiation of bradykinin (BK) or inhibited formation of angiotensin II (AII). Anesthetized adult mongrel dogs were used in the current study. In each, the right femoral vein and artery were cannulated for the administration of drugs and monitoring of arterial pressure. A tracheostomy was performed, and the animal was respired with room air. It was found that after injection of endotoxin, AII receptor blockade (Sar1, Ile8-AII) produced a mean arterial pressure (MAP) response statistically similar to that elicited by captopril in combination with endotoxin. Although these results indicate no production of BK, the possibility of BK receptor inactivation during endotoxin shock cannot be disregarded. Additional studies suggested that in the dog, injections of BK can augment the depression of MAP caused by endotoxin and that this further depression can be prolonged by captopril. On the basis of these results, it can be concluded that in the early phases of canine endotoxin shock, AII plays a significant role in the maintenance of MAP and that BK is not produced in quantities sufficient to lower MAP.

Angiotensin-Converting Enzyme Inhibitors↗

Blood volume changes in endotoxin shock.

Injection of E. coli endotoxin in dogs promotes hemodynamic changes in circulating blood volume and blood components. Adult mongrel dogs were given endotoxin and studied for 3 hours. Red-blood-cell (RBC) volume and whole-blood volume was measured using the Cr-51 RBC labeling method. Hematocrit and RBC counts were taken at various time periods. Whole-blood volume was not found to change significantly over the test period; however, plasma volume demonstrated a significant decrease by 60 minutes with a parallel increase in RBC volume. Hematocrit increased significantly by 60 minutes and continued its rise to a 30% increase at 3 hours. Circulating RBC counts demonstrated a 26% increase. RBC precursors such as reticulocytes and normoblasts were counted using standard microscopic methods and were observed to increase after injection of endotoxin. These data suggest that the increases in hemoconcentration after administration of endotoxin are caused not only by the loss of plasma from the circulation but also by release of RBCs from blood-forming organs.

Animals↗

The spread of tumor-cell-sized particles after bone biopsy.

For the purpose of determining possible passive dissemination of tumor cells from a bone biopsy site, we created an animal model. A cortical window was placed in the canine femur and a measured quantity of radioactive microspheres was placed in the medullary canal. Local and distant spread of the microspheres were measured four days after the simulated biopsy. In the animals in which the cortical window was left open, spread of the microspheres was limited to the adjacent tissue and the regional lymph nodes. In the animals in which the bone window was plugged with methylmethacrylate, there was little or no local spread of the microspheres; however, there was significant uptake of the microspheres in the lung. In a separate trial, significant microsphere activity was present in the lung within twenty minutes after placement of the methylmethacrylate plug.

Animals↗

Cyclic sequential compression of the lower limb in prevention of deep venous thrombosis.

Patients undergoing operations on the hip for either replacement or fracture were chosen for this study. Fifty-two subjects received cyclic sequential compression as well as elevation of the lower limb while another fifty-two patients were treated with only elevation of the lower limb. No other method of prophylaxis for deep venous thrombosis was employed during the study period. Support stockings were used after removal of the compression device. Doppler ultrasound, phleborheography, and, when possible, radioiodinated fibrinogen scanning were used for identification and location of thrombi. A deep-vein thrombosis developed in ten patients (19 per cent) in the control group and in only one patient (2 per cent) in the group that was treated with compression. This difference is statistically significant (p less than 0.05).

Aged↗